Driehaus Capital Management
Driehaus Capital Management reported 399 stocks worth $14.4B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are TSM (2.9%), DFTX (1.8%) and GH (1.8%). Compared with Q2 2026, the fund opened new positions in ZETA, WPM and PBR, added to BAP, IBN and BAND, trimmed TSM, DFTX and GH and sold out of PL, VICR and CW.
Latest filing: what Driehaus Capital Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() TSM Taiwan Semiconductor Mfg Ltd | $412M | 2.9% | 904K | −81K (−8%) | 8 of 8 | |
| 2 | ![]() DFTX Definium Therapeutics Inc | $258M | 1.8% | 6.8M | −57K (−1%) | 4 of 8 | |
| 3 | ![]() GH Guardant Health Inc | $258M | 1.8% | 1.4M | −88K (−6%) | 7 of 8 | |
| 4 | ![]() PRAX Praxis Precision Medicines I | $246M | 1.7% | 846K | −113K (−12%) | 8 of 8 | |
| 5 | ![]() SYRE Spyre Therapeutics Inc | $246M | 1.7% | 2.8M | −39K (−1%) | 8 of 8 | |
| 6 | ![]() BAP Credicorp Ltd | $222M | 1.5% | 586K | +28K (+5%) | 8 of 8 | |
| 7 | ![]() IBN Icici Bank Limited | $191M | 1.3% | 6.9M | +2.1M (+43%) | 8 of 8 | |
| 8 | ![]() EWTX Edgewise Therapeutics Inc | $179M | 1.2% | 4.4M | −327K (−7%) | 8 of 8 | |
| 9 | ![]() XMTR Xometry Inc | $177M | 1.2% | 1.7M | −42K (−2%) | 8 of 8 | |
| 10 | ![]() SEPN Septerna Inc | $167M | 1.2% | 4.3M | −160K (−4%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CRINETICS PHARMACEUTICALS IN | $242M | 6.5M |
APOGEE THERAPEUTICS INC | $231M | 1.7M |
![]() PL Planet Labs Pbc | $223M | 6.7M |
![]() VICR Vicor Corp | $189M | 497K |
![]() CW Curtiss Wright Corp | $174M | 229K |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Driehaus Capital Management 13F FAQ
What does Driehaus Capital Management own?
Driehaus Capital Management reported 399 stocks worth $14.4B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are TSM (2.9%), DFTX (1.8%) and GH (1.8%). The table above lists every position in the filing (the top 10 without an account).
What did Driehaus Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 145 new positions, 106 added to, 126 trimmed and 100 sold out. New positions include ZETA, WPM and PBR. It sold all of PL, VICR and CW.
When will Driehaus Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Driehaus Capital Management's portfolio worth?
The Q3 2026 filing reports $14.4B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.


























